rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

20 Sep,12:21
6728.35
0.35 (0.01%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

158 6,728.00 6,782.80 - 6,698.15 7,550.00 - 4,050.15 16,820.88
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

20 Sep,12:38
6724.90
8.65 (0.13%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

1,691 6716.25 6,785.00 - 6,680.00 7,572.20 - 4,311.00 113.86

News for AstraZeneca Pharma India Ltd.

Tamil Nadu...
Tamil Nadu Approves Rs 44,125 Cr Projects, Renewable Energy Policies
Tamil Nadu cabinet approves 15 investment proposals worth Rs 44,125 crore, including renewable energy policies and projects in electronics, food processing, and more. The state aims to generate...
Aug 13, 2024 17:55
AstraZeneca India Reports Q1 Net Loss of Rs 12 Crore
AstraZeneca Pharma India reported a net loss of Rs 12 crore for the first quarter ended June 30, 2024, compared to a profit of Rs 54 crore in the same period last year. Total income for the quarter...
Aug 08, 2024 18:49
Sanofi Gets CDSCO...
Sanofi Gets CDSCO Nod for Beyfortus in India - Prevention of RSV
Sanofi India receives marketing authorization for Beyfortus, a treatment for preventing Respiratory Syncytial Virus (RSV) in infants and children up to 24 months.
Aug 01, 2024 13:34
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
AstraZeneca...
AstraZeneca Withdraws COVID Vaccine: Surplus of Updated Vaccines
AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...
May 08, 2024 14:34

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

Vivad Se Vishwas...
Vivad Se Vishwas 2.0: Govt Notifies Oct 1 Start Date
The government has notified October 1 as the start date for the Vivad Se Vishwas 2.0 scheme, which aims to resolve income tax disputes. The scheme offers a chance for taxpayers to settle pending...
Sep 20, 2024 12:32
PhysicsWallah...
PhysicsWallah Raises USD 210 Million, Valuation Soars to USD 2.8 Billion
PhysicsWallah, an Indian edtech unicorn, secures USD 210 million in funding led by Hornbill Capital, boosting its valuation to USD 2.8 billion. The company plans to utilize the funds for strategic...
Sep 20, 2024 12:28
Emerging Asia's...
Emerging Asia's Mobility Sector to Absorb USD 1.3 Trillion in Green Funds by 2030
A new report highlights the rapid growth of the mobility sector in emerging Asian markets, predicting USD 1.3 trillion in green investment by 2030. Electric vehicles, particularly scooters and...
Sep 20, 2024 11:54
Reliance Infra...
Reliance Infra Gets Rs 1,100 Crore Infusion from Promoters
Reliance Infrastructure Ltd is set to receive Rs 1,100 crore equity infusion from promoters and Rs 1,910 crore from Mumbai-based investors. The company seeks shareholder approval for the fund raise...
Sep 20, 2024 11:44
India Not...
India Not 'Abuser' of Tariffs, Trump's Claims Unfair: GTRI
GTRI refutes former US President Donald Trump's claims that India is an 'abuser' of import tariffs, citing WTO data showing high US tariffs on various products. The think tank argues that Trump's...
Sep 20, 2024 11:20

More News »

Top News

Vivad Se Vishwas...
Vivad Se Vishwas 2.0: Govt Notifies Oct 1 Start Date
The government has notified October 1 as the start date for the Vivad Se Vishwas 2.0 scheme, which aims to resolve income tax disputes. The scheme offers a chance for taxpayers to settle pending...
Sep 20, 2024 12:32
PhysicsWallah...
PhysicsWallah Raises USD 210 Million, Valuation Soars to USD 2.8 Billion
PhysicsWallah, an Indian edtech unicorn, secures USD 210 million in funding led by Hornbill Capital, boosting its valuation to USD 2.8 billion. The company plans to utilize the funds for strategic...
Sep 20, 2024 12:28
Emerging Asia's...
Emerging Asia's Mobility Sector to Absorb USD 1.3 Trillion in Green Funds by 2030
A new report highlights the rapid growth of the mobility sector in emerging Asian markets, predicting USD 1.3 trillion in green investment by 2030. Electric vehicles, particularly scooters and...
Sep 20, 2024 11:54
Tirupati Laddu...
Tirupati Laddu Controversy: Probe Ordered into Animal Fat Allegations
India's food minister calls for an investigation into allegations that animal fat was used in Tirupati laddus, sparking concern among devotees. Andhra Pradesh CM Chandrababu Naidu claims the...
Sep 20, 2024 11:53
Reliance Infra...
Reliance Infra Gets Rs 1,100 Crore Infusion from Promoters
Reliance Infrastructure Ltd is set to receive Rs 1,100 crore equity infusion from promoters and Rs 1,910 crore from Mumbai-based investors. The company seeks shareholder approval for the fund raise...
Sep 20, 2024 11:44

More Top News »

Report Card

PE Ratios
104.99
EPS (Rs.)
64.60
Sales (Rs. Cr)
387.52
Face Value (Rs.)
2
Net Profit Margin (%)
12.46
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
22.68

BSE Announcements from AstraZeneca Pharma India Ltd. (See all)

announcement Launch Of Palivizumab (Synagis) - 1 day(s) ago
announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 13 Sep 2024

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,832.65
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,079.35
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,568.25
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,033.30
  • Compare
  • Max Healthcare Institute Ltd.
  • 961.95
  • Compare
  • Alkem Laboratories Ltd.
  • 6,091.55
  • Compare
  • Divi's Laboratories Ltd.
  • 5,468.30
  • Compare

Most Active

  • Change (Rs.)
  •  

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close